Prescription opioid (PO) abuse has reached epidemic proportions in the United States, and pharmacies are locations from which these medications are often diverted. This study identifies factors associated with pharmacists who currently screen and discuss PO misuse with patients.
Methods:
A secondary data analysis of a cross-sectional Web-based survey that was sent to pharmacists was conducted. The survey contained items that assessed whether pharmacists currently screened and discussed PO misuse with patients along with pharmacists’ attitudes and beliefs toward providing brief interventions. Multivariable models were developed which identified factors associated with pharmacists’ currently screening and discussing misuse.
Results:
Chain setting pharmacists (odds ratio [OR] = 6.16, 95% confidence interval [CI] = 1.16-32.72) and pharmacists interested in being directly involved in PO screening and brief intervention research projects (OR = 2.06, 95% CI = 1.35-3.15) were most likely to report current screening. Pharmacists who reported currently screening for misuse (OR = 4.27, 95% CI = 2.83-6.45) and who reported wanting to help patients who misuse POs (OR = 3.03, 95% CI = 1.50-6.15) were most likely to currently discuss abuse.
Conclusions:
Investigators implementing pharmacy-based screening and brief intervention studies for POs should take into account practice location and pharmacists’ interest in addressing PO issues.
Centers for Disease Control. Morbidity and Mortality Weekly Report. Vital Signs: Overdoses of Prescription Opioid Pain Relievers—United States, 1999–2008. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
2.
Substance Abuse & Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse & Mental Health Services Administration; 2012.
3.
HumeniukRAliRBaborT. A randomized controlled trial of a brief intervention for illicit drugs linked to the alcohol, smoking and substance involvement screening test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction. 2012;107(5):957–966.
4.
BernsteinJBernsteinETassiopoulosK. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005;77(1):49–59.
5.
HeatherNBowieAAshtonH. Randomised controlled trial of two brief interventions against long-term benzodiazepine use: outcome of intervention. Addict Res Theory. 2004;12(2):141–154.
6.
NilsenPBairdJMelloMJ. A systematic review of emergency care brief alcohol interventions for injury patients. J Subst Abuse Treat. 2008;35(2):184–201.
7.
BeichAThorsenTRollnickS. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. BMJ. 2003;327(7414):536–540.
8.
BertholetNDaeppenJBWietlisbachV. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med. 2005;165(9):986–995.
9.
HavardAShakeshaftASanson-FisherR. Systematic review and meta-analyses of strategies targeting alcohol problems in emergency departments: interventions reduce alcohol-related injuries. Addiction. 2008;103(3):368–376.
10.
Drug Policy Alliance. Overdose: A National Crisis Taking Root in Texas. New York: Drug Policy Alliance; 2010.
11.
ZahradnikAOttoCCrackauB. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction. 2009;104(1):109–117.
12.
CiceroTJKurtzSPSurrattHL. Multiple determinants of specific modes of prescription opioid diversion. J Drug Issues. 2011;41(2):283–304.
13.
InciardiJASurrattHLKurtzSP. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007;8(2):171–183.
14.
Gallup Politics. Nurses have highest honesty rating; car salespeople, lowest; 2012. http://www.webcitation.org/6HzfDAEfZ. Accessed July 9, 2013.
15.
DhitalRWhittleseaCMNormanIJ. Community pharmacy service users’ views and perceptions of alcohol screening and brief intervention. Drug Alcohol Rev. 2010;29(6):596–602.
16.
CochranGFieldCLawsonK. Pharmacists’ knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists. J Pharm Health Serv Res. 2013;4(2):71–79.
17.
Substance Abuse and Mental Health Services Administration. Nonmedical Use of Pain Relievers in Substate Regions: 2004 to 2006. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008.
18.
Centers for Disease Control. Policy Impact: Prescription Drug Overdose State Rates; 2011. http://www.webcitation.org/6Hzjup8rQ. Accessed July 9, 2013.
19.
State of Texas. Professional responsibility of pharmacists. In: Texas Board of Pharmacy Administrative Code, ed. 22. Vol 291. 29. State of Texas; 2011.
20.
State of Utah. Pharmacy Practice Act. In: State of Utah, ed. 58. Vol 17b. State of Utahl; 2004.
21.
FitzgeraldNWatsonHMcCaigD. Developing and evaluating training for community pharmacists to deliver interventions on alcohol issues. Pharm World Sci: 2009;31(2):149–153.
22.
SheridanJWheelerAJu-Hsing ChenL. Screening and brief interventions for alcohol: attitudes, knowledge and experience of community pharmacists in Auckland, New Zealand. Drug Alcohol Rev.2008;27(4):380–387.
23.
Stata. Version 12.1. College Station, TX: StataCorp; 2012.
24.
HosmerDWLemeshowS. model-building strategies and methods for logistic regression. Applied Logistic Regression. New York: John Wiley & Sons, Inc; 2005:91–142.
25.
ParrishDEvon SternbergKVelasquezMM. Characteristics and factors associated with the risk of a nicotine exposed pregnancy: expanding the CHOICES preconception counseling model to tobacco. Matern Child Health J. 2012;16(6):1224–1231.
26.
DolanSMCoxSTepperN. Pharmacists’ knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women. J Am Pharm Assoc. 2012;52(1):43–51.
27.
PollardSRClarkJS. Survey of health-system pharmacy leadership pathways. Am J Health Syst Pharm. 2009;66(10):947–952.
28.
PinnekeS. Variable infusion rates associated with TKO/KVO abbreviations: a survey of Illinois hospital pharmacists. Hosp Pharm. 2010;45(7):549–551.
29.
O’ReillyCLBellJSChenTF. Pharmacists’ beliefs about treatments and outcomes of mental disorders: a mental health literacy survey. Aust N Z J Psychiatry. 2010;44(12):1089–1096.
30.
InquillaCCSzeinbachSSeoane-VazquezE. Pharmacists’ perceptions of computerized prescriber-order-entry systems. Am J Health Syst Pharm. 2007;64(15):1626–1632.
31.
DroegeMAssa-EleyMT. Pharmacists as care providers: Personal attributes of recent pharmacy graduates. Am J Pharm Educ. 2005;69(3):290–295.
32.
DöhlerNKrolopLRingsdorfS. Task allocation in cancer medication management – Integrating the pharmacist. Patient Educ Couns. 2011;83(3):367–374.
33.
KypriK. Methodological issues in alcohol screening and brief intervention research methodology, trial, screening, brief intervention, alcohol, drinking. Subst Abuse. 2007;28(3):31.
34.
Substance Abuse and Mental Health Services Administration. SAMHSA SBIRT Grantees; 2011. http://www.webcitation.org/6I0pKYTey. Accessed July 10, 2013.
35.
CochranGFieldC. Brief Intervention and social work: a primer for practice and policy. Soc Work Public Health. 2013;28(3/4):248.
36.
JamisonRNRossELMichnaE. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010;150(3):390–400.
